Green light in the US for the booster dose of Pfizer-BioNTech’s anti-Covid vaccine for children aged 5-11. The Food and Drug Administration today changed the Emergency Use Authorization (Eua) for this product, authorizing the administration of a single booster to children of this age group, at least 5 months after the completion of the primary course of two doses with the Pfizer-BioNTech vaccine.
